However, the following clinicopathological features showed no significant association with BGN expression: M stage, N stage, residual tumor, gender, age, primary therapy outcome, and Barrett’s esophagus (Figures 5F,H–L, p > 0.05). This evidence concerns the gene BGN and Barrett esophagus.